Zimbabwe has turned down a significant American healthcare agreement worth 367 million US dollars (£272m) spanning five years due to the United States' demand for sensitive information.
This rejection came to light following a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesperson has since explained that the United States was seeking biological samples for research and commercial purposes while refused to share the resulting advantages from any future treatments.
"We are forced to start the difficult and regrettable process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had furnished more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for more talks to secure a deal acceptable to all parties so the nation's critical HIV programme can proceed.
Wider Implications
This rejection comes after a similar situation in Kenya, where a high court suspended a similar health funding agreement after concerns were raised about the safety of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was seeking direct bilateral agreements to boost transparency and responsibility.
According to reports, 16 nations in Africa have so far signed these new health pacts, constituting over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation could have provided immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, without any equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Put simply, our nation would provide the raw materials for medical research with no certainty that the resulting innovations would be available to our people if a future health crisis emerge."
National Interest and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral deals were upending structures already established through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to manage future global health emergencies.
"This mechanism is intended to ensure that when a nation provides its data, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to continued discussions with our American counterparts on how subsequent collaboration might be arranged in a manner that respects the sovereignty and dignity of each country."
Health Experts Reaction
A leading public health body stated it understood the official position, but recommended that negotiations need to persist given that a large portion of the country's HIV programmes depended on international support.
"Where specific concerns arise, such as those relating to information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," the group said.
The situation highlights the ongoing tensions between accepting much-needed international aid and protecting local interests in an increasingly data-driven world.